Valsartan and Similar Hypertension Drugs Had No Effect On COVID-19 Survival: Study
A new study questions whether hypertension drugs have a negative impact on patients with COVID-19 infections.
A new study questions whether hypertension drugs have a negative impact on patients with COVID-19 infections.
A new study finds that valsartan and similar drugs do not increase the risk of poor outcomes from COVID-19.
New study questions whether hypertension drugs increase severity of COVID-19.
Some researcher warn that blood pressure medications like valsartan and Benicar could increase the severity and lethality of the coronavirus.
A losartan lawsuit claims generic versions of the drug were tainted with impurities which caused colon cancer.
European regulators are reviewing other hypertension drugs, fearing the same impurities which led to valsartan recalls may be found in similar medications.
Federal drug safety experts say they can find no link between cancer and a popular class of blood pressure control medications, which include Benicar, Atacand, Avapro, Cozaar, Diovan, Micardis and…